From animal experiments to clinical trials: aspects of the transposition in psychopharmacology.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001522:Behavior, Animal / Q000187:drug effects; D001569:Benzodiazepines; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D003220:Conflict, Psychological; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D009638:Norepinephrine / Q000378:metabolism; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012701:Serotonin / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D012701:Serotonin; D005680:gamma-Aminobutyric Acid; D008094:Lithium; D009638:Norepinephrine